Unknown

Dataset Information

0

Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.


ABSTRACT: Basal-like breast cancer (BLBC) accounts for approximately 15% of all breast cancer cases, and patients with BLBC have a low survival rate. Our previous study demonstrated that the KLF5 transcription factor promotes BLBC cell proliferation and tumor growth. In this study, we demonstrated that the histone deacetylase inhibitors (HDACi), suberoylanilide hydroxamic acid (SAHA), and trichostatin A (TSA), increased KLF5 acetylation at lysine 369 (K369), downregulated KLF5 protein expression levels, and decreased cell viability in BLBC cell lines. HDACi target KLF5 for proteasomal degradation by promoting KLF5 protein ubiquitination. K369 acetylation of KLF5 decreases the binding between KLF5 and its deubiquitinase, BAP1. These findings revealed a novel mechanism by which HDACi suppress BLBC, and a novel crosstalk between KLF5 protein acetylation and ubiquitination.

SUBMITTER: Kong Y 

PROVIDER: S-EPMC8935240 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.

Kong Yanjie Y   Ren Wenlong W   Fang Huan H   Shah Naseer Ali NA   Shi Yujie Y   You Dingyun D   Zhou Chengang C   Jiang Dewei D   Yang Chuanyu C   Liang Huichun H   Liu Wenjin W   Wang Luzhen L   Gan Wenqiang W   Wan Xing X   Li Fubing F   Li Zhen Z   Chen Ceshi C   Xie Ni N  

International journal of biological sciences 20220228 5


Basal-like breast cancer (BLBC) accounts for approximately 15% of all breast cancer cases, and patients with BLBC have a low survival rate. Our previous study demonstrated that the KLF5 transcription factor promotes BLBC cell proliferation and tumor growth. In this study, we demonstrated that the histone deacetylase inhibitors (HDACi), suberoylanilide hydroxamic acid (SAHA), and trichostatin A (TSA), increased KLF5 acetylation at lysine 369 (K369), downregulated KLF5 protein expression levels, a  ...[more]

Similar Datasets

| S-EPMC5384641 | biostudies-literature
| S-EPMC9816171 | biostudies-literature
| S-EPMC4424404 | biostudies-literature
| S-EPMC8481478 | biostudies-literature
| S-EPMC5884928 | biostudies-literature
| S-EPMC2168912 | biostudies-literature
| S-EPMC4117710 | biostudies-literature
| S-EPMC6176919 | biostudies-literature
| S-EPMC4155692 | biostudies-literature
| S-EPMC7307093 | biostudies-literature